55403-25-3 Usage
Description
1-(2-CHLORO-4-NITRO-PHENYL)-PIPERIDINE is a chemical compound with the molecular formula C11H13ClN2O2, belonging to the class of piperidine derivatives. It features a 2-chloro-4-nitrophenyl group attached to the piperidine ring, which endows it with unique structural and functional properties. 1-(2-CHLORO-4-NITRO-PHENYL)-PIPERIDINE is known for its potential biological activities and is being explored for its use in the treatment of various diseases.
Uses
Used in Pharmaceutical Industry:
1-(2-CHLORO-4-NITRO-PHENYL)-PIPERIDINE is used as a building block for the synthesis of various drugs and bioactive molecules. Its unique structural properties allow it to serve as a key component in the development of new pharmaceuticals, targeting a range of diseases and conditions.
Used in Chemical Synthesis:
In addition to its pharmaceutical applications, 1-(2-CHLORO-4-NITRO-PHENYL)-PIPERIDINE is also utilized as a chemical intermediate in the synthesis of other organic compounds. Its versatile structure makes it a valuable asset in the creation of a wide array of chemical products.
Used in Medical and Pharmacological Research:
Due to its potential to interact with various biological targets, 1-(2-CHLORO-4-NITRO-PHENYL)-PIPERIDINE is being researched for its possible application in medicine and pharmacology. This includes the development of new therapeutic strategies and the enhancement of existing treatments for various diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 55403-25-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,4,0 and 3 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 55403-25:
(7*5)+(6*5)+(5*4)+(4*0)+(3*3)+(2*2)+(1*5)=103
103 % 10 = 3
So 55403-25-3 is a valid CAS Registry Number.
55403-25-3Relevant articles and documents
GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE
-
Paragraph 001550; 001551; 001831; 001832, (2021/01/22)
Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with a defect in glyoxylate metabolism, for example a disease or disorder associated with the enzyme glycolate oxidase (GO) or alterations in oxalate metabolism. Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.
9-(P-phenylazoanilino)-7-methyl-1H-imidazo[4,5-f]quinolines
-
, (2008/06/13)
A series of 9-(substituted amino)imidazo[4,5-f]quinolines are effective anthelmintic agents; particularly in respect to the tapeworm Hymenolepis nana.
